Mentioned in ?
References in periodicals archive ?
Another potential source of SRL pharmacokinetic variability was the rs4253728G>A polymorphism in PPARA.
2]); PECAMI platelet/ endothelial cell adhesion molecule (CD31 antigen); AGTRI, angiotensin II receptor, type 1; AGTR2, angiotensin II receptor, type 2; BDKRBI, bradykinin receptor B1; BDKRB2, bradykinin receptor B2; PPARA, peroxisome proliferator-activated receptor-[alpha]; F7, coagulation factor VII (serum prothrombin conversion accelerator); CETP, cholesteryl ester transfer protein.
058 activated receptor, gamma, coactivator 1, alpha peroxisome proliferative PPARA 2.